Forbes & Company
- Market cap
- ₹ 343 Cr.
- P/E
- 30.4x
- P/B
- 1.68x
- 52-week range
- 242.2 – 462.75
- ROE
- 2%
- ROCE
- 5%
- Dividend yield
- 0%
- Debt / equity
- 0.03
- Sector
- Consumer Durables
- Industry
- Household Appliances
- Listed on
- BSE
About
Forbes & Company Limited is an India-based company. It operates through two segments: coding and industrial automation and real estate. The coding and industrial automation segment includes manufacturing/trading in conventional and automatic marking systems and industrial automation business. The Company, through its Bradma business, specializes in coding & industrial automation. The real estate segment is engaged in renting out investment properties and real estate development projects. It is developing Vicinia, the premium residential experience in Powai. Vicinia features eight multi-story towers. It is engaged in developing payment processing and transaction automation solutions. It has established a national network operations and control center, which provides, among other things, remote monitoring, and real-time transaction monitoring services. It is a provider of self-service kiosks in the insurance sector. It supplies automated ticket vending machines to Indian Railways.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Household Appliances: 26 companies →Forbes & Company against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)30.4 against a typical 35.1: cheaper than most peers (1st = cheapest).10th of 26
- Sales growth−40.9% against a typical +16.3% from a year earlier.25th of 26
- Profit growth−25.9% against a typical +39.1% from a year earlier.18th of 25
- Share price, 3 months+13% against a typical −12.6%.4th of 26
- Size₹ 343.1 Cr. market value against a typical ₹ 3,242.3 Cr. (1st = largest).19th of 23
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16 | 12 | 87 | 36 | 35 | 40 | 89 | 22 | 19 | 18 | 17 | 13 |
| Expenses | 17 | 12 | 84 | 31 | 30 | 37 | 77 | 21 | 16 | 15 | 18 | 12 |
| Operating Profit | −2 | 0 | 4 | 5 | 4 | 3 | 12 | 1 | 3 | 3 | −1 | 1 |
| OPM % | −9.7% | 0.7% | 4% | 13.4% | 12.2% | 8.7% | 13% | 5.1% | 15.4% | 17% | −4.7% | 8.5% |
| Other Income | −20 | 3 | −1 | 2 | 3 | 10 | 97 | 5 | 6 | 3 | 1 | 4 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | −23 | 3 | 1 | 6 | 6 | 13 | 108 | 6 | 8 | 5 | −1 | 4 |
| Tax % | 0.5% | −56% | −173.4% | 18.6% | 17.6% | 27.2% | 5% | 15.6% | 24.5% | 14.3% | 131.8% | 12.2% |
| Net Profit | −23 | 4 | 3 | 5 | 5 | 10 | 103 | 5 | 6 | 4 | −2 | 4 |
| EPS in Rs | −17.6 | 3.05 | 2.63 | 4.09 | 3.98 | 7.36 | 79.72 | 3.77 | 4.91 | 3.25 | −1.53 | 2.79 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- −31%
- 5 Years
- −39%
- 3 Years
- 18%
- TTM
- −64%
- 10 Years
- 7%
- 5 Years
- −38%
- 3 Years
- 29%
- TTM
- −56%
- 10 Years
- 20%
- 5 Years
- 24%
- 3 Years
- −2%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 17%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Forbes & Company | ₹ 286.20 | ₹ 343 Cr. | 30.4x | 1.7x | 2% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 64.9x | 13.4x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 71.5x | 9.9x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.9x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 102.6x | 9.3x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 48.1x | 9.1x | 19.9% | 10.3% |
Management
- Jagannath Govale
- Chief Financial Officer
- Mehul Raval
- Compliance Officer, Company Secretary
- Nirmal Jagawat
- Whole-time Director
Prices are delayed and for information only. Nothing on this page is investment advice.